SCHEMBL21363678

SCHEMBL21363678

C=CCc1cc2c(cc1OCc1ccccc1C)OCO2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.45
CCND1 P24385 1/20 0.45
CYP3A4 P08684 3/20 0.42
MAPT P10636 2/20 0.42
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.41
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
PREP P48147 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
TSHR P16473 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
ADRA2A P08913 2/20 0.39
ADRA2B P18089 2/20 0.39
ADRA2C P18825 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21363605 0.87 POLB (0.48) CYP3A4MAPTCYP1A2POLBKMT2A
SCHEMBL21363748 0.87 NPC1 (0.46) CDK4CCND1CYP3A4MAPTCYP1A2
SCHEMBL21363746 0.86 USP2 (0.44) CYP3A4MAPTCYP1A2POLBKMT2A
SCHEMBL21363612 0.86 HPGD (0.44) CYP3A4MAPTCYP1A2KMT2AMEN1
SCHEMBL14552348 0.84 MAOB (0.54) CYP3A4MAPTCYP1A2POLBKMT2A
SCHEMBL21363610 0.84 KMT2A (0.41) CYP3A4MAPTCYP1A2POLBKMT2A
SCHEMBL21363606 0.83 SLC6A4 (0.41) CYP3A4MAPTCYP1A2KMT2AMEN1
SCHEMBL21363747 0.81 CDK4 (0.41) CDK4CCND1MAPTKMT2AMEN1
SCHEMBL21366571 0.80 CDK4 (0.43) CDK4CCND1MAPTKMT2AMEN1
SCHEMBL21363758 0.78 CYP3A4 (0.63) CYP3A4MAPTCYP1A2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019175712-A1 NEW USES FOR CATECHOL MOLECULES AS INHIBITORS TO GLUTATHIONE S-TRANSFERASE METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed